ID Biomedical Corporation Chief Executive Officer Anthony Holler discusses the vaccine makers' business during an interview in Toronto, February 22, 2005. The Canadian company develops and produces warfare vaccines as well as the influenza vaccine that was in short supply this past year, in Canada and the United States. REUTERS/J.P. Moczulski JPM/HB